Cita APA

Pascual-Marmaneu, O., Belles-Medall, M., Ferrando-Piqueres, R., Almela-Notari, P., Mendoza-Aguilera, M., & Alvarez-Martin, T. (2021). Serum levels of infliximab and adalimumab are associated with deep remission in inflammatory bowel disease.

Citación estilo Chicago

Pascual-Marmaneu, O., MD Belles-Medall, R. Ferrando-Piqueres, P. Almela-Notari, M. Mendoza-Aguilera, y T. Alvarez-Martin. Serum Levels of Infliximab and Adalimumab Are Associated With Deep Remission in Inflammatory Bowel Disease. 2021.

Cita MLA

Pascual-Marmaneu, O., et al. Serum Levels of Infliximab and Adalimumab Are Associated With Deep Remission in Inflammatory Bowel Disease. 2021.